
Allotar Therapeutics aims to expand treatment options by discovering safer, targeted therapies. Its AllotarX engine blends physics-based simulations and AI to map disease proteins and identify allosteric sites. It focuses on neurodegenerative diseases and ion channel disorders, with potential oncology and rare disease programs. The approach targets partnerships for milestone-driven development and late-stage commercialization. The company operates as a biotech R&D platform.

Allotar Therapeutics aims to expand treatment options by discovering safer, targeted therapies. Its AllotarX engine blends physics-based simulations and AI to map disease proteins and identify allosteric sites. It focuses on neurodegenerative diseases and ion channel disorders, with potential oncology and rare disease programs. The approach targets partnerships for milestone-driven development and late-stage commercialization. The company operates as a biotech R&D platform.